decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 3 (March)
Combating Reduced Drug Prices
Subscribe or sign in to view the full article.
Article Overview
This premium article examines how declining drug reimbursements affect ophthalmology practices, especially those treating age-related macular degeneration with photodynamic therapy. It focuses on Medicare payment changes, practice-level financial pressure, and the business considerations that can influence whether a practice continues offering treatment. The content is aimed at ophthalmology billing staff, practice managers, and providers who need to understand the reimbursement environment and its operational impact.
Why This Topic Matters
Reduced drug pricing can directly affect whether a practice can sustain treatment offerings, especially for high-cost therapies used in retina care. Understanding the reimbursement context helps practices evaluate operational risk and plan around payer-driven payment changes.
What You Will Learn
- How reduced drug reimbursements can affect practice operations
- The general reimbursement context surrounding photodynamic therapy
- Why payment changes can create financial pressure for ophthalmology practices
- The role of distributor and practice-level negotiation in managing cost pressure
Who Should Read This
- Ophthalmologists
- Retina specialists
- Practice managers
- Medical billers and coders
- Ophthalmology administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com